Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. by Kranzer, Katharina et al.
Kranzer, K; Houben, RM; Glynn, JR; Bekker, LG; Wood, R; Lawn,
SD (2010) Yield of HIV-associated tuberculosis during intensified
case finding in resource-limited settings: a systematic review and




Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution Non-commercial No Derivatives
http://creativecommons.org/licenses/by-nc-nd/2.5/
Supplementary webappendix
This webappendix formed part of the original submission and has been peer reviewed. 
We post it as supplied by the authors. 
Supplement to: Katharina Kranzer, Rein M G J Houben, Judith R Glynn, 
Linda-Gail Bekker, Robin Wood, Stephen D Lawn. Yield of HIV-associated tuberculosis 
during intensiﬁed case ﬁnding in resource-limited settings: a systematic review and 
meta-analysis. Lancet Infect Dis 2010; 10: 93–102.
Search strategy 





3   Set 1 and 2 were combined with "or" 
4 screening 
5 MASS SCREENING 
6 (active or enhanced or intensified) adj1 (case adj1 finding) 
7 CONTACT TRACING 
8 
screening 
(household adj1 contact*) or (contact adj1 tracing) 





(isoniazid adj1 preventive adj1 therapy) or ipt 
13 HIV/AIDS AIDS-RELATED OPPOTUNISTIC INFECTION, PREVENTION AIDS AIDS 
14   Set 10-13 were combined with "or" 
15 PRISONS or PRISONERS 




20 refugee* or (internally adj1 displaced)  
21 HOSPITALS, PSYCHIATRIC psychiatric adj1 hospital psychiatric adj1 hospital 
22 SUBSTACE ABUSE, INTRAVENOUS INTRAVENOUS DRUG ABUSE INJECTING DRUG ABUSE 
23 (injecting adj1 drug adj1 user) or ivdu (injecting adj1 drug adj1 user) or ivdu 
(injecting adj1 drug adj1 user) or 
ivdu 
24 PROSTITUTION 
25 prostitute* or csw or (commercial adj1 sex) or prostitution 
26 HOMOSEXUALITY, MALE 









vct or (voluntary adj1 counselling adj1 testing) 
29   Set 15-28 were combined with "or" 
30   Set 29, 14 and  9 were combined with "or" 
31   Set 30 and 3 were combined with "and" 
32   set 31 was limited to years "1994-2009" 
33   set 32 and (search strategy "country")1 were combined with "and" 
          
Words written in capital letters were used as MeSH headings, the others were used as free text. Search terms 
which were the same for all databases are only mentioned once under the EMBASE heading 
1 search strategy "country" combined all midlle and low income countries (MeSH heading and free text) with or 
 
Congregate settings            








screen  Exam TST CXR antibiotics S C 
TB 
prevalence Comments prevalence 
Prisons and correctional facilities 
Aerts22 2000 1997-98 Georgia 7630 7473* 1     (2)   2(MMM) 3 5.99% 445 S+/C+; 3 S-/C+ 
Salek23 2001 1999 Iran 2212 2212 1 2   2   2   0.68% 10 S+; 5 clin 
Askarian24 2001 1997 Iran 319 319     1 (10) 2   3 4 2.50% 4 S+/C+/CXR+; 4 S-/C-/CXR+ 
Yazdanpana25 1999   Iran 1634 1634   1   2   2   0.12% 1 S+; 1 clin 
Rao26 2004 2002 Pakistan 4870 4870 1     2   2(SSS)   0.66% 1 S+/CXR+; 31 S-/CXR+ 
Shah27 2003 2002 Pakistan 386 386 1         2(SMS)   3.89% 9 S+; 6 clin 
Noeske28 2006 2003-04 Cameroon 2830 2474* 1       3 2(MM) 4(MM) 2.43% 60 S+ or C+ 
Koffi29 1997 1990-02 Ivory Coast 1861 1861 1 1   3   2   7.20% 108 S+; 26 S-/CXR+ 
Wang30 2003 2002 Botswana 1173 1027* 1     (2)   2(XXX) 2(XX) 1.85% 8S+; 11 S- 
Banerjee31 2000 1997 Malawi 275 111* 1 1       2(XXX)   3.60% 4 S+  
Nyangulu32 1997 1996 Malawi 1315 900* 1     4 3 2(SMS)   3.70% 18 S+;15 S-/clin 
Habeenzu33 a 2007 2000-01 Zambia 6118* 1069 (1)         2(MMM) 2(MMM) 4.00% 168 S+/C+; 77 S-/C+ 
Pillay34 2003  South Africa 7341 7341 1         2 (2) 1.82%   
Naranbat35 2001   Mongolia 4811 4021*       1   2   2.04%   
Jittimanee36 2007 2004-05 Thailand 71594 71594 1         2(SSS)   0.35% 254 S+ 
Sretrirutchai37 2002 1998 Thailand 4751 4751 1     2   3 3 0.57% 27 S+/CXR+ 
Sanchez38 2007 2005 Brazil 1377 1372*       1   2(XX) 2(XX) 3.86% 36 S+/C+; 17 S-/C+ 
Abrahao39 2006 2000-01 Brazil 1122 1052* 1
a   1b(5)     2(X or XX) 
2(X or 
XX) 2%
c 8 S+/C+; 13 S-/C+ 
Fournet40 2006 2003 Brazil 789 581* 1     1   2(XX) 2(XX) 5.50% 17 S+; 12 S-/C+; 3 clin 
Sanchez41 2005 2002 Brazil 1171 1052* 1     1   2(XX) 2(XX) 4.09% 14 S+; 14 S-/C+; 15 clin 
Ferreira42 1996 1992-93 Brazil 378 350* 1 1   2   1(XX) 1(XX) 5.71% 2 S+; 15 S-/C+; 3 clin 
Psychiatric hospitals                           
Van Duc43 2008 2005 Vietnam 300 300 1     1   2(XX)   0.33% 1 S+ 
Mines                             
Steen44 d 1997 1994 Botswana 303 303   1   1   2   1.32% 4 S+ 
Fielding45 2008 2006-07 South Africa 13482 13482 1     1   2(X) 2(X) 1.16%   
Girdler-Brown46 d 2008 1999 South Africa 779 624* 1     1   2(XXX) 2(XXX) 4.97% 18 S+ or C+; 13 clin 
Day47 e 2006 1999-01 South Africa 1310 899* 1 1   1   1(SS) 1(SS) 4.89% 35 C+; 4 C-/cli, 5 EPTB 
Corbett48 2004 2000-01 South Africa 2248 1734* 1     1   1(XX) 1(XX) 2.70% 9 S+/C+; 36 S-/C+; 2 clin 
Aungkasuvapala49 1995 1995 Thailand 676 676   1   1   1(XXX)   1.92% 8 S+/CXR+; 5 S-/CXR+ 
  
Refugees and internally displaces                       
Weinstock50 2001 1999 Georgia 4000 931* 1   1 (10) 2   3(MMM) 3(MMM) 0.54% 2 C+; 1 C-/CXR+; 2 C?/CXR+ 
Nelson51 2003 2002-03 Botswana 2777 1615* 1     3
f   2(XXX)   0.25%   
  asymptomatic prisoners were asked to present for screening,  basymptomatic prisoners had 1 smear and culture symptomatic prisoners and prisoners with positive TST had 2 smears and cultures, c3 of the active TB cases were on TB 




VCT, PMTCT, high risk groups            
Author 



























s S C 
TB 
prevalence Comments prevalence 
VCT 
Shetty52 2008 2003-04 India 4479 4479 5142 5142 1         2   HIV+ 0.81%   HIV- 0.91% 51 S+; 20 S-; 12 EPTB 
Shah53 2009 2005-06 Ethiopia 453 438*     1 1   1   1(SMS) 
1(SMS
) 7.31% 9 S+/C+; 18 S-/C+, 5 S+/C-  
Mugisha54 2006 2001--03 Uganda 7453 6305*     1 1   4 3 2   4.65% 190 S+; 91 S-; 12 EPTB 
Aisu55 1995 1991-92 Uganda 1524* 1424     1     2   2   5.60%   
Godfrey-
Faussett56 1995   Zambia 181 90*     1 1   1   2 2 5.50%   
Naidoo57 2002 2000-01 South Africa 2261 1126*     1     2   2 2 9.77% 





5 2001-03 Cambodia 1979 876*     1 1   (1)   1   23.63%   




16.13%        
HIV- 2.42% 
19 S+; 10 C+ 
Espinal61 1995 1991-93 Dom. Rep. 350 200* 364 200* 1 1 1 (5) 2   
2(XX
X)   
HIV+ 
14.50%        
HIV- 5.00% 
29 S+; 4 S-/clin; 6 EPTB 




10.55%        
HIV- 3.05% 
HIV+ 11 S+/C+; 14 S-/C+; 25 S-
/C-                            
HIV- 17 S+/C+; 9 S-/C- 
PMTCT or postpartum care 
Gupta63 b 2007 2002-05 India 715 688*     1   1 (5)   2 2 2 3.49% 
6 C+; 12 S+;                    
12 clin (16 pTB, 2 pTB/EPTB, 6 
EPTB) 
Kali64 2006 2003 South Africa 545 370*     1         2 2 2.12% 8 S-/C+ 
Nachega65 2003 2001 South Africa 438* 318     2   
1 




X) 2.30% 6 C+; 5 S+; 2 clin (4 pTB, 9 EPTB) 
High risk groups (MSM and IVDU) 
Khanani101 2008   Iran 700c 700c     1         2(XXX)   6.00%   
aThe total number of VCT clients eligible for screening=1220 (no break-down according to HIV status), bWomen were followed for a maximum of 12 months after giving birth 7 TB cases were found within the first 2 weeks 
of delivery, c300 IDUs and 200 MSMs (HIV positive and HIV negative) were screened 
Hospital, clinic based, home based screening 








screen  Exam TST CXR antibiotics S C 
TB 
prevalence Comments prevalence 
Swaminathan66 2000 1989-93 India 
STD clinic 
attendees 487 175* 1 1   1   2(XXXX) 2(XXXX) 9.71%   
Dhungana67, 68 2008 2004-05 Nepal 
Out- and 
inpatients 100 100           1(SMS) 1(SMS) 7.00% 
1 S+/C-; 4 S+/C+; 2 S-
/C+ 
Khun69 2002 2001 Cambodia Home-based 773 773 1 1   1   2 2 13.58% 29 S+; 29 S-/C+, 46 S-/C-/clin; 20 EPTB 
Kimerling70 2002 2000 Cambodia Home-based 787 441*           1(S) 1(S) 9.30% 29 S+/C+; 12 S-/C+ 
Ngowi71 2008 2006-07 Tanzania 
HIV/ARV 
clinic 233 233           1(S) 1(S) 8.58% 8 S+/C+; 12 S-/C+ 
Bakari/Mtei9, 72 a 2008/2005 2001-03 Tanzania HIV clinic 1176 1176 1     1   1(XXX) 1(XXX) 11.56% 
2S+/C-; 13 S+/C+; 23 S-
/C+;    98 S-/C-/clin 
Nakanjako73 2007 2005-06 Uganda HIV clinic 2469 2469 1     2   2 (XXX)   7.78%   
Were/Moore74, 75 2007/2009 2003-05 Uganda 
HIV/ARV 
clinic 1995 1995 1     4 3 2 (SMS) 4 3.56% 
14 S+; 53 S-/clin; 
4EPTB 
Gasana76 2008 2006 Rwanda HIV clinic 629 300* 1     2   2   3.67%   
Bassett77 2009 2007-08 
South 
Africa ARV clinic 824 824 1         1 1 19.30% 14 S+/C+, 145 S-/C+ 
Lawn10 2009 2007-08 
South 
Africa ARV clinic 235 235 1         1(SS) 1 (SS) 24.68% 8 S+/C+, 50 S-/C+ 
Mohammed78 2004   South Africa HIV clinic 140 129* 1     1   1(S) 1(S) 8.53% 
6 S+/C+; 4S-/C+; 1 C-
/clin 
Reddy79 2008   Peru HIV clinic 471 435*           1(XX) 1(XX) 6.21% 7 S+/C+, 20 S-/C+  
Silva80 2004 2001-02 Brazil Inpatients  547 547 1     1   2 2 1.83% 3 S+/C+; 7 S-/C+ 
Murcia81 2001 1999-00 Colombia HIV clinic 286 286           1 1 1.40% 2 pTB; 2 EPTB 
Crespo82 1999   Colombia social service 155 155       1   2 2 6.45% 
1 pTB; 6 miliary TB        
2 TB meningitis; 1 lymph 
node TB 

















screen  Exam TST CXR antibiotics S C 
TB 
prevalence Comments prevalence 
Demissie93 2002 2001 Ethiopia 12149 12149 1         2(SMS)   0.17% 21 S+ 
Sekandi94 2009 2005  Uganda 1000 930 1         2(SMM)   3.50% 33 S+ 
Guwatudde95 2003 2001-02 Uganda 1142 1142 1     2   2(SMM) 2(SMM) 0.70%   
Corbett96 2007   Zimbabwe 10079 10079           1(SM) 1(SM) 0.65% 40 S+/C+, 26 S-/C+ 
Corbett97 2007 2001 Zimbabwe 4884 4668* 1     3   2(XXX) 2(XXX) 0.58% 6 S+/C+; 15 S-/C+; 6 clin 
den Boon98, 99 2006/2007 2002 South Africa 3971 2608*       1   1(S) 1(S) 1.11% 
20 S+/C+; 7 S-/C+; 2 scanty 
smear 
Wood11 2007 2005 South Africa 971 762*           1(MS) 1(MS) 1.57% 6 S+/C+; 6 S-/C+ 





































Kuaban83  1996 1993-94 Cameroon 336 104 416 346* 1   1 (10) 1   2   14.45% 
25 S+; 25 clin (25 cases in 
children <14) 
Jackson-Sillah84 2007 2002-04 
The 
Gambia 317 317 2381 2174* 1   1 (10) 2 4 3 3 1.52% 
6 S+/C+; 18 S-/C+; 6 clin (16 
cases in children <14) 
Diatta85 2007 2003-04 Senegal 30 30 601 601 2 2 1 (8) 2   3   2.66% 
16 S+                       
(2 cases in children<15) 
Guwatudde86 2003 1995-99 Uganda 360 302 1206 1206 1 1   1   2(XXX) 2(XXX) 4.23% 
13 S+/C+; 9 S-/C+; 9 S+/C-; 16 
clin (34 cases in children<6)  
Zachariah87 2003 2001-02 Malawi 87 87 461 461 1
a         2(SM)   1.74% 2 S+; 6 clin (4 cases in children <6) 
Suggaravetsiri88 2003 2000-02 Thailand 499 459 1200 1192 1 1 1 (15) 2   
2(MM
M) 3 3.75%   
Becerra89 2005 1997-98 Peru 208 208 1094 1094 1         2(MM) 2(MM) 0.70%   
Bayona90 2003 1996-99 Peru 192 192 945 945 1         2   0.01%   
Carvalho91 2003 1995-97 Brazil 191 86 371 360* 1   1(10/5)
b 1   2 2 0.83%   
Teixeira92 2001 1994-98 Brazil 78
c 78 408* 364 1 1 1 (10) 2   2 2 4.17%   








TST=Tuberculosis skin test, CXR= chest radiograph, S=sputum smear, C=sputum culture, clin=clinical, EPTP=extrapulmonary TB, pTB=pulmonary TB 
Numbers indicate the order in which investigational screening tools were used in the screening process. For example the prison study by Aerts et al. performed symptom screening 
first indicated by a “1” in the symptom column. Individuals with symptoms had a CXR and sputum smears indicated by a “2” in these columns. All positive sputum smears were 
cultured indicated by a “3”. 
Numbers in brackets in TST column indicate the cut-off for TST positivity. For example the study by Askarian et al. used a TST cut-off of 10mm. 
A number in brackets in the CXR column indicates that CXRs were not performed on everybody (see prison study by Aerts et al.) 
The number of letters in the smear and culture columns indicates the number of smears/cultures examined. “M” indicates early morning sputum, “S” indicates spot sputum and “X” 
indicates that the time when sputum was taken was unknown. In the prison study by Aerts et al. sputum smear examination were performed on 3 early morning sputum samples 
indicated by three “Ms”. Studies without alphabetical letters did not report the number or timing of sputum samples.  
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